Elasmogen Ltd is a next generation therapeutic biologics company discovering and developing soloMERs™ for the treatment of auto-immune mediated, inflammatory diseases. Utilising its unique soloMER™ platform, Elasmogen exploits the power of biologics as drugs but in small, simple, and stable formats that are amenable to site-specific delivery.
Member count: 11-50
Total raised: $2.560962M
Founded date: 2016
Investors 1
| Date | Name | Website |
| 18.05.2022 | BGF Ventur... | bgf.co.uk |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 13.01.2020 | - | $2.560962M | - | eu-startup... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 13.01.2020 | Scottish E... | Aberdeen-based biotech startup... | Funding U... | Charlotte ... | eu-startup... |
| 08.01.2019 | Elasmogen ... | Aberdeen-based company Elasmog... | - | - | digit.fyi/... |